GLYCOMIMETICS INC Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Glycomimetics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Glycomimetics Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 64.5M shares, a 0.18% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 64.5M +115K +0.18% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 64.5M +171K +0.27% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 64.5M +206K +0.32% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 64.4M +10M +18.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 64.4M +11.9M +22.8% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 64.3M +11.9M +22.7% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 64.2M +11.9M +22.6% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 54.4M +2.06M +3.95% Dec 31, 2022 10-K 2024-03-27
Q3 2022 52.4M +685K +1.32% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 52.4M +885K +1.72% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 52.4M +853K +1.66% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 52.3M +3.3M +6.73% Dec 31, 2021 10-K 2023-03-29
Q3 2021 51.7M +3.91M +8.18% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 51.5M +4.82M +10.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 51.5M +7.96M +18.3% Mar 31, 2021 10-Q 2021-05-03
Q4 2020 49M +5.55M +12.8% Dec 31, 2020 10-K 2022-03-03
Q3 2020 47.8M +4.47M +10.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 46.7M +3.52M +8.15% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 43.6M +403K +0.93% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 43.5M +306K +0.71% Dec 31, 2019 10-K 2021-03-02
Q3 2019 43.4M +223K +0.52% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 43.2M +138K +0.32% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 43.2M +690K +1.62% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 43.2M +8.8M +25.6% Dec 31, 2018 10-K 2020-02-28
Q3 2018 43.1M +10.4M +31.8% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 43.1M +10.3M +31.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 42.5M +18.6M +78.1% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 34.4M +11.1M +47.8% Dec 31, 2017 10-K 2019-03-06
Q3 2017 32.7M +9.67M +41.9% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 32.7M +9.69M +42.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 23.9M +4.58M +23.7% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 23.3M +4.2M +22% Dec 31, 2016 10-K 2018-03-06
Q3 2016 23.1M +4.03M +21.2% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 23M +4.01M +21.1% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 19.3M +274K +1.44% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 19.1M +110K +0.58% Dec 31, 2015 10-K 2017-03-01
Q3 2015 19M +143K +0.76% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 19M +126K +0.67% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 19M +225K +1.2% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 18.9M +17.5M +1228% Dec 31, 2014 10-K 2016-02-29
Q3 2014 18.9M Sep 30, 2014 10-Q 2014-10-31
Q2 2014 18.9M Jun 30, 2014 10-Q 2014-07-31
Q1 2014 18.8M Mar 31, 2014 10-Q 2014-05-09
Q4 2013 1.43M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.